Previous studies have demonstrated that the lack of interleukin-21 (IL-21) signalling could affect specific antibody induction after rabies vaccination. Here, to further investigate the overexpression of IL-21 on the immunogenicity of rabies virus (RABV), a recombinant RABV expressing murine IL-21, designated LBNSE-IL21, was constructed and evaluated in a mouse model. It was found that in mice immunized with LBNSE-IL21, there was a substantial increase in the number of T follicular helper cells and germinal centre B cells but no enhancement of dendritic cell activation. Furthermore, significantly higher rabies virus-neutralizing antibody (VNA) titres were produced in mice immunized with LBNSE-IL21 than in mice immunized with the parent virus LBNSE in the first six weeks, resulting in higher protection. Together, these results suggest that LBNSE-IL21 can induce a rapid and robust VNA titre, and it has the potential to be developed as a promising rabies vaccine.
Rabies, caused by the rabies virus (RABV), results in acute inflammation of the brain in humans and warm-blooded mammals, with a case-fatality rate near 100 % (Fooks et al., 2014) . There are approximately 59 000 reported human deaths globally each year, most of which occur in the developing countries of Africa and Asia where rabies is endemic in dogs (Hampson et al., 2015) . Nearly 95 % of human rabies cases in these countries are related to dog bites, indicating that it is critical to control rabies in dogs to eliminate rabies in humans in these countries (Faber et al., 2009) . In a previous study, at least 70 % vaccination coverage of the canine population has been suggested to efficiently block the transmission of RABV from dog to human (Franka et al., 2013; Schnell et al., 2010) . Domestic dog vaccination provides a cost-effective choice in the prevention and elimination of human rabies (Wunner & Briggs, 2010) . However, the level of dog vaccination is largely based on the availability of vaccines (Franka et al., 2013) . Due to the relatively low protective immunity of inactivated rabies vaccines currently used, multiple injections are necessary to achieve protective immunity, resulting in a relative high cost. Therefore, the development of affordable rabies vaccines that are capable of inducing robust immunity is urgently needed for rabies control in developing countries with high rabies incidence.
IL-21, secreted by CD4+ T-cell populations -with the highest production by T follicular helper (Tfh) cells and Th17 cells, is a member of the common g chain-dependent cytokine family, which includes IL-2, IL-4, IL-7, IL-9 and IL-15 (Leonard, 2001) . IL-21 acts on Tfh cells in an autocrine manner that can up-regulate the transcription factors Bcl-6 and MAF45, which are required for the efficient development of Tfh cells (Nurieva et al., 2009; Ozaki et al., 2002; Yu et al., 2009) . Additionally, IL-21 can also directly impact B-cell function through maximizing the expression of Bcl-6 to promote germinal centre (GC) B-cell development and survival, and it acts as a potent inducer of plasma cell (PC) differentiation through the expression of Blimp-1 (Ozaki et al., 2004) . It has been demonstrated that a lack of the IL-21 receptor influences the detection of B cells in lymph node germinal centres or of plasma cells in a model of rabies immunogenicity and protection, suggesting that IL-21 may be a potential adjuvant in rabies vaccine development (Dorfmeier et al., 2013) .
inserted into the genome of the RABV strain LBNSE between the G and L genes, resulting in LBNSE-IL21 (Fig. 1a) . LBNSE is derived from a SAD B19 strain with two mutations at amino acid positions 194 and 333 of the G protein to reduce the viral pathogenicity (Conzelmann et al., 1990; Seif et al., 1985; Wen et al., 2011) . After rescuing LBNSE-IL21, as described previously (Zhou et al., 2015) , BSR and NA cells were infected with either LBNSE-IL21 or LBNSE at a multiplicity of infection (m.o.i.) of 0.01. Multi-step growth curves were generated based on the viral titres at each time point. As shown in Fig. 1(b, c) , both growth curves of LBNSE-IL21 were similar to that of the parent virus LBNSE, indicating that the viral replication was not affected by the insertion of the IL-21 gene. The quantity of IL-21 in the cell culture was measured by a commercial ELISA kit, indicating that IL-21 was produced in a dosedependent manner (Fig. 1d ).
To investigate whether infection with recombinant RABVs (rRABVs) can affect cell viability, BSR cells were infected with LBNSE-IL21 or LBNSE at an m.o.i. of 1 and cell viability was measured with a Cell Proliferation Assay kit (Promega). The results showed that cell viability was not significantly affected by the expression of IL-21 (Fig. 1e) . Furthermore, the viral pathogenicity of LBNSE-IL21 in vivo was evaluated. Mice (n=10) were inoculated intracranially (ic) with 2Â10 6 f.f.u. of LBNSE or LBNSE-IL21, or with an equivalent volume of DMEM, and their body weights were measured daily for 2 weeks. No clinical signs were observed in any of the infected mice. The body weight changes in mice infected with LBNSE-IL21 were similar to those infected with LBNSE ( Fig. 1f) , suggesting that both LBNSE and LBNSE-IL21 are avirulent in vivo.
Our previous study showed that rRABVs expressing chemokines or cytokines could induce higher virus-neutralizing antibody (VNA) titres by activating dendritic cells (DCs) and B cells in immunized mice or dogs (Zhao et al., 2010; Zhou et al., 2013 Zhou et al., , 2015 . To investigate whether overexpression of IL-21 could induce DC activation, mice (n=10) were immunized through the intramuscular (im) route with 10 6 f.f.u. of LBNSE, LBNSE-IL21 or an equal volume of DMEM. Lymph nodes and blood from immunized mice were collected at days 3 and 6 post-infection (p.i.) to measure DC activation. The representative gating strategies for activated DCs (CD11c + and CD80 + or CD11c + and CD86 + ) are shown in Fig. 2(a, d) . No significant difference was observed in the proportion of activated DCs in the lymph node (Fig. 2b , e) and blood (Fig. 2c, f) samples between the LBNSE and LBNSE-IL21 groups at days 3 and 6 p.i., indicating that over-expression of IL-21 did not induce increased DC activation. The effect of IL-21 on DC activation remains controversial. One previous study showed that IL-21 could inhibit DC activation and maturation (Brandt et al., 2003) , while another suggested that IL-21 presents different effects on plasmacytoid DCs (pDC) and conventional DCs (cDC) in vivo (Wan et al., 2013).
Since DC activation was not significantly affected by expression of IL-21, we investigated its effect on antibody induction processes after antigen presentation. GC is the primary area where high-affinity antibodies are produced by interaction between B cells and T follicular helper cells. One potential way to increase GC output is to increase the population of Tfh cells or alter Tfh cell function (Linterman & Hill, 2016) . IL-21 has been shown to be essential for Tfh cell development and IL-21-/-or IL-21R -/-mice displayed a severe defect in the numbers of Tfh cells (Nurieva et al., 2008; Vogelzang et al., 2008) . Therefore, we next examined Tfh and GC B-cell development post-immunization with different rRABVs. Balb/c mice (n=5) were immunized (via im injection) with 10 6 f.f.u. of LBNSE or LBNSE-IL21 or the same volume of DMEM. Inguinal lymph nodes from immunized mice were collected at days 7 or 14 p.i. to analyse the Tfh and GC B-cell populations in the different immunization groups. The representative gating strategies for detecting Tfh cells and GC B cells are shown in Fig Fig. 2h) . Nevertheless, in a previous study, the ratio of Tfh cells was shown to be similar in IL-21 receptor knock-out mice compared to wild-type mice after immunization with rabies vaccine, suggesting that IL-21 is dispensable in the generation of Tfh cells (Dorfmeier et al., 2013) . This result, however, does not contradict our finding because generation of Tfh cells is not solely affected by IL-21; other cytokines can functionally compensate for the lack of IL-21 for Tfh cell differentiation. For instance, IL-6 can directly induce Tfh cell differentiation in an IL-6-rich environment, and the level of Tfh cell differentiation was lower in the absence of both IL-6 and IL-21 than that in the absence of IL-21 alone (Vogelzang et al., 2008) .
Meanwhile, significantly more GC B cells (B220 + , FAS + , GL7 + ) were detected at both days 7 and 14 p.i. in mice immunized with ILBNSE-IL-21 than in mice immunized with LBNSE (Fig. 2j) . This might also contribute to the elevated Tfh cell population and could lead to increased interactions between Tfh cells and GC B cells. In addition, IL-21 has a vital role throughout life in B-cell development, including GC B cells, through inducition of maximal expression of Bcl-6 that is highly expressed in GC B cells during GC reactions (Linterman et al., 2010) . Plasma cells (PCs), which exist mainly in the bone marrow, are antibody-secreting cells differentiated from GC B cells. Thus, we further investigated the role of IL-21 in the regulation of PCs post-rRABV immunization. PCs were collected from bone marrow and identified as B220 lo and CD138 + ; representative gating strategies for PCs are shown in Fig. 2 (k). Consistent with the VNA titres, the percentage of PCs was significantly higher in the bone marrow of mice immunized with LBNSE-IL21 than in those mice immunized with LBNSE (Fig. 2l) 
Log virus titre (f.f.u. ml Weeks post-infection VNA GMT titre (IU) 5 6 7 Fig. 3 . Virus-neutralizing antibody (VNA) induction, RABV-specific antibody isotype identification, and protection after lethal challenge in rRABV-immunized mice. Six-week-old female ICR mice (n=10) were immunized im with 10 6 f.f.u. of LBNSE or LBNSE-IL21 or mock-immunized with DMEM. Blood samples were collected and separated sera were used to test VNA by FAVN at each time point, as described in the main text. The VNA titres are shown as mathematical mean (a) and geometric mean (b). At the indicated times points, RABV-specific IgG1 (c), IgG2a (d), IgG2b (e), IgG3 (f), IgG (g) and IgM (h) antibodies were determined by ELISA. Before measuring the absorbance at 450 nm (OD 450 ) for RABV-specific IgG1, IgG2a, IgG2b, IgG3, IgG and IgM antibodies, sera were diluted 1 : 30, 1 : 800, 1 : 1600, 1 : 30, 1:30, 1 : 6400 and 1 : 30 times, respectively. Data are presented as mean±SE (n=10), analysed by unpaired t-test. (i) The survivor ratio of each immunization group after challenge. Groups of ICR mice (n=25) were immunized im with 10 6 f.f.u. of LBNSE, LBNSE-IL21 or the same volume of DMEM. At day 21 p.i., mice were challenged by the ic route with 50-fold the mouse intracranial lethal dose 50 (MICLD 50 ) of In regard to rabies, VNA is one of the most critical factors related to protection (Hooper et al., 1998) . To further investigate the role of IL-21 expression on the induction of anti-RABV antibodies, serum samples from immunized mice were collected weekly from the first to the seventh week postimmunization, to perform VNA titres by FAVN (fluorescent antibody virus neutralization) as described previously (Tian et al., 2016) . Briefly, 50 µl serial three-fold dilutions of test and standard serum were prepared on 96-well microplates in 100 µl volumes. Each sample was added to four adjacent wells. A 50 µl volume of CVS-11 suspension, containing 50-200 f.f. u., was added to each well. After incubation at 37 C for 1 h in an incubator with 5 % CO 2 , 50 µl cell suspension, containing 2Â10 4 BSR cells, was added to each well, followed by incubation at 34 C with 5 % CO 2 for 60 h. The plates were then fixed in 80 % ice-cold acetone at À20 C for 30 min and stained with FITC-conjugated antibodies against the RABV N protein for 45 min at 37 C. After staining, cells were washed three times with PBS. Results were assessed using an Olympus IX51fluorescence microscope. VNA titres were expressed in IU ml À1 by comparison to the titre of a reference serum (obtained from the National Institute for Biological Standards and Control, Herts, UK) included in each test. As shown in Fig. 3(a) , the mice immunized with LBNSE-IL21 produced significantly higher levels of VNA as early as *1 week postimmunization compared to those immunized with LBNSE, and these levels lasted for 6 weeks. At 7 weeks post-immunization, the mean VNA titre in mice immunized with LBNSE-IL21 was 19.7 IU ml À1 , which was still higher than the 12.8 IU ml À1 detected in LBNSE-immunized mice, although the difference was not significant. The dynamics of geometric mean titres (GMT) of VNA are also presented, and we found the highest VNA was 45.14 and 18.85 IU ml À1 in the LBNSE-IL21 and LBNSE groups induced at 5 and 4 weeks postimmunization, respectively (Fig. 3b) . These results indicate that over-expression of IL-21 enhanced the induction of VNA in mice immunized with LBNSE-IL21 compared to those immunized with LBNSE.
To further analyse the RABV-specific antibody isotypes and IgG subclasses induced in immunized mice, 6-week-old female ICR mice (n=10) were immunized by the im route with 10 6 f.f.u. of LBNSE, LBNSE-IL21 or DMEM. The sera from immunized mice were isolated and analysed with ELISA. Briefly, 96-well ELISA plates were coated with 100 µl well À1 of purified RABV proteins (0.5 µg well
À1
) in 50 mM sodium bicarbonate buffer (pH=9.6) overnight at 4 C and blocked in buffer with 5 % milk for 8 h at 4 C. The plates were then incubated with serially diluted mouse sera at room temperature for 2 h. After washing, the plates were incubated with diluted HRP-conjugated goat antimouse IgG, IgM, IgG1, IgG2a, IgG2b or IgG3 antibodies for 1 h. Finally, the plates were incubated with SureBlue tetramethylbenzidine peroxidase substrate solution (Beyotime), the reaction was stopped by addition of 2M H 2 SO 4 , and the absorbance at 450 nm was measured with a Spectra MAX 190 microplate reader (Molecular Devices). As shown in Fig. 3(c, d) , significantly higher levels of IgG1 and IgG2a were detected in mice immunized with LBNSE-IL21 than in those immunized with LBNSE at all tested time points. For IgG2b, significantly higher levels were detected in LBNSE-IL21 immunized mice at 1, 4 and 5 weeks post-immunization (Fig. 3e) . IgG1 is associated with the stimulation of Th2-type immune responses that can regulate humoral immune responses. It was demonstrated that IL-21 is a switch factor for IgG1, and the IgG1 level was lower in IL-21 receptor-deficient mice after immunization than in the wild-type mice (Ozaki et al., 2002) . IgG2a and IgG2b, stimulated during Th1-type immune responses, were suggested to be the main form of immunoglobulin induced by rabies vaccines (Singh & O'Hagan, 1999; Snapper & Paul, 1987) . A previous study showed that IL-21 induced the production of IgG3 in human B-cell development (P ene et al., 2004) . However, no significant difference in the IgG3 level was observed between the LBNSE-IL21-and LBNSE-immunized groups, (Fig. 3f) , suggesting that the mechanism for IgG3 induction might be different between humans and mice. Moreover, total IgG and IgM levels were also measured in that study. As expected, a significantly high level of RABV-specific total IgG was observed in LBNSE-IL21-immunized mice at all time points except for 2 weeks postimmunization (Fig. 3g) , while a significant difference was only observed at 1 week post-immunization for the IgM level (Fig. 3h) .
Furthermore, the protection test was also carried out at 21 days post-immunization. ICR mice were given 50 times the mouse intracranial lethal dose 50 (MICLD 50 ) of CVS-24 and observed daily for 3 weeks. As shown in Fig. 3(i) , all mice in the mock group succumbed to the challenge within 2 weeks, and 92.0 % of those immunized with LBNSE-IL21 were protected against the pathogenic RABV challenge, which was significantly higher than the percentage of the mice immunized with LBNSE (68.0 %). These results are consistent with VNA titres induced in the immunized mice.
In summary, our results indicate that immunization with LBNSE-IL21 generated more Tfh cells, GC B cells and PCs than LBNSE immunization, resulting in enhanced VNA production and improved protection. Our study suggests that LBNSE-IL21 is a promising rabies vaccine candidate.
